Skip to main content
. 2024;25(9):3097–3104. doi: 10.31557/APJCP.2024.25.9.3097

Table 2.

Laboratory Characteristics of the Three Studied Groups

HCC group n=38 Cirrhosis group n=38 Control group n=38 p-value
p3=0.095
Hemoglobin (gm/dL) 11.4±1.3 11.7±2.1 13.2±0.9 <0.001 p1=0.659
p2<0.001
p3=0.010
TLC x103 6.6±3.8 6.7±2.9 7.1±2.2 0.693
Platelet count x103 151±61 174±82 250±54 <0.001 p1=0.467
p2<0.001
p3=0.001
Albumin (gm/dL) 3.23±0.49 3.51±0.53 4.54±0.62 <0.001 p1=0.325
p2<0.001
p3=0.012
T. Bilirubin (mg/dL) 1.5 (0.8-4.3) 1.1 (0.1-3.3) 0.7 (0.1-1.8) 0.002 p1=0.039
p2=0.004
p3=0.633
D. Bilirubin (mg/dL) 0.7 (0.1-2.2) 0.4 (0.1-1.6) 0.3 (0.2-0.7) 0.057
ALT (IU/mL) 48 (12-198) 28 (12-139) 20 (12-28) 0.005 p1=0.241
p2=0.005
p3=0.183
AST (IU/mL) 55 (18-271) 35 (1-78) 17 (10-30) <0.001 p1<0.001
p2<0.001
p3=0.078
INR 1.53±0.37 1.33±0.21 1.02±0.09 <0.001 p1=0.161
p2<0.001
p3=0.001
S. creatinine (mg/dL) 1.16±0.39 0.99±0.33 0.83±0.27 0.003 p1=0.341
p2=0.002
p3=0.300
B. urea (mg/dL) 32.5 (15-98) 24 (12-45) 18 (6-23) 0.001 p1=0.148
p2=0.001

Data are presented as mean±SD or median (range); TLC,Total leucocytic count; ALT, Alanine transaminase; AST, Aspartate aminotransferase; INR, International normalized ratio; p1, HCC vs. Cirrhosis; p2, HCC vs. Control; p3, Cirrhosis vs. Control